NCT03499808 2025-09-09
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
Phase 2 Completed
SWOG Cancer Research Network
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Children's Oncology Group